Clinical Trials Browser

Phase 2 × Kidney Neoplasms × siltuximab × Clear all

NCT00311545 2013-02-20

S0351, CNTO 328 in Treating Patients With Unresectable or Metastatic Kidney Cancer

Phase 2 Withdrawn

Carcinoma, Renal Cell, Kidney Neoplasms